A1L131
Gene name |
Cuedc2 |
Protein name |
CUE domain-containing protein 2 |
Names |
|
Species |
Rattus norvegicus (Rat) |
KEGG Pathway |
rno:294009 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for A1L131
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-A1L131-F1 | Predicted | AlphaFoldDB |
No variants for A1L131
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for A1L131 | |||||
No associated diseases with A1L131
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| nuclear membrane | Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space. |
| nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
1 GO annotations of molecular function
| Name | Definition |
|---|---|
| ubiquitin binding | Binding to ubiquitin, a protein that when covalently bound to other cellular proteins marks them for proteolytic degradation. |
2 GO annotations of biological process
| Name | Definition |
|---|---|
| negative regulation of cytokine production involved in inflammatory response | Any process that stops, prevents or reduces the frequency, rate or extent of cytokine production involved in inflammatory response. |
| negative regulation of macrophage cytokine production | Any process that decreases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MELERIVSSA | LFAFVQTHLP | EADLSGLDEV | IFSYVLGVLE | DLGPSGPSEE | NFDMEAFIEM |
| 70 | 80 | 90 | 100 | 110 | 120 |
| MEAYVPGFAH | IHRGIIEDMV | QTLSVQLSSA | RNKETLRRPE | KLKEESRPPA | ATGNTQDEAA |
| 130 | 140 | 150 | 160 | 170 | 180 |
| AAEEEQPGVD | VLLEVFPTCS | MEQAQWVLAK | ARGNLEEAVQ | MLIEGKEEGP | PGWGGPNQDL |
| 190 | 200 | 210 | 220 | 230 | 240 |
| PRRLRGPRKE | ELKSFILQKY | MMVDRAEDQK | THRPMAPKEA | PKKLIRYIDN | QVVSTKGERF |
| 250 | 260 | ||||
| KDVRNPETEE | MKATYINLKP | ARKYRFH |